» Articles » PMID: 2579912

Interferon in Experimental Autoimmune Encephalomyelitis (EAE): Effects of Exogeneous Interferon on the Antigen-enhanced Adoptive Transfer of EAE

Overview
Publisher Karger
Date 1985 Jan 1
PMID 2579912
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The transfer of experimental autoimmune encephalomyelitis (EAE) can be enhanced by incubating lymph node cells (LNC) from EAE rats with myelin basic protein (MBP). Addition of rat fibroblast interferon (RfIFN) to cultures of EAE-LNC just before the addition of MBP, resulted in the inhibition of the adoptive transfer of EAE. Both development of clinical signs, such as weight loss and hind limb paralysis, and histopathological lesions, lymphocytic perivascular infiltrates of the central nervous system, were inhibited by the addition of RfIFN to a final concentration of 300 U/ml or higher. This inhibition was dose dependent and appeared to be mediated primarily by the antiproliferative action of RfIFN.

Citing Articles

Signaling pathways and therapeutic perspectives related to environmental factors associated with multiple sclerosis.

Tiwari S, Lapierre J, Ojha C, Martins K, Parira T, Kumar Dutta R J Neurosci Res. 2018; 96(12):1831-1846.

PMID: 30204260 PMC: 7167107. DOI: 10.1002/jnr.24322.


Microglial production of TNF-alpha is induced by activated T lymphocytes. Involvement of VLA-4 and inhibition by interferonbeta-1b.

Chabot S, Williams G, Yong V J Clin Invest. 1997; 100(3):604-12.

PMID: 9239408 PMC: 508228. DOI: 10.1172/JCI119571.


Mechanisms of action of interferon-beta in multiple sclerosis.

Arnason B, Dayal A, Qu Z, Jensen M, Genc K, Reder A Springer Semin Immunopathol. 1996; 18(1):125-48.

PMID: 8984676 DOI: 10.1007/BF00792613.


The efficacy of cyclosporin A, FK-506 and prednisolone to modify the adoptive transfer of experimental allergic encephalomyelitis (EAE).

Bolton C Agents Actions. 1992; 35(1-2):79-84.

PMID: 1380765 DOI: 10.1007/BF01990955.


Interferons in multiple sclerosis. A review of the evidence.

Panitch H Drugs. 1992; 44(6):946-62.

PMID: 1282865 DOI: 10.2165/00003495-199244060-00004.